Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received April 17, 2024
- Revision received April 24, 2024
- Accepted April 25, 2024
- Published online June 27, 2024.
Copyright & License
Copyright © 2024 The Author(s). Published by the International Institute of Anticancer Research. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY-NC-ND) 4.0 international license (https://creativecommons.org/licenses/by-nc-nd/4.0).
Author Information
- 1Department of Radiation Oncology, University of Lübeck, Lübeck, Germany;
- 2Department of Radioneurosurgery, Romodanov Neurosurgery Institute, Kyiv, Ukraine;
- 3Department of Radiation Oncology, Mayo Clinic, Phoenix, AZ, U.S.A.;
- 4Department of Neurosurgery, University of Lübeck, Lübeck, Germany
- Correspondence to: Professor Dirk Rades, MD, Department of Radiation Oncology, University of Lübeck, Ratzeburger Allee 160, 23562 Lübeck, Germany. Tel: +49 45150045401, Fax: +49 45150045404, e-mail: dirk.rades{at}uksh.de
Statistics from Altmetric.com
Cited By...
In this issue
Jump to section
Related Articles
Cited By...
- Preoperative Tumor Growth Rate Does Not Predict Overall or Progression-free Survival in Patients With Glioblastoma
- Therapy Intensity Outweighs the Prognostic Importance of the Timing of Chemoradiotherapy in Newly Diagnosed Glioblastoma Patients
- The Predictive Value of Different Glasgow Prognostic Scores and the LabBM Score for Patients With Recurrent Glioblastoma